C. Nemecek

发表

Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors.

C. Venot, H. Strobel, D. Lesuisse, 2011, Bioorganic & medicinal chemistry letters.

Design of Potent IGF1‐R Inhibitors Related to Bis‐azaindoles

C. Venot, W. Metz, F. Ding, 2010, Chemical biology & drug design.

2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections.

M. Otto, E. De Clercq, L. Naesens, 2002, Antiviral research.

Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines.

S. Mignani, P. Hubert, J. Stutzmann, 1999, Journal of medicinal chemistry.

A short route to chiral sulfoxides using titanium-mediated asymmetric oxidation

H. Kagan, C. Nemecek, P. Pitchen, 1985 .

Versatile Methods for the Synthesis of 2-Amino-6-trifluoromethoxy-(nitro)benzothiazoles

S. Mignani, C. Gueremy, C. Nemecek, 1992 .

Kinetic Resolution by Asymmetric Oxidation of Racemic 4-Azetidinyl p- Tolyl Sulfide with t-Butylhydroperoxide in Presence of a Chiral Titanium Complex.

H. Kagan, C. Nemecek, 1995 .

The Selective Intravenous Inhibitor of the MET Tyrosine Kinase SAR125844 Inhibits Tumor Growth in MET-Amplified Cancer

J. Nicolas, F. Bégassat, C. Egile, 2014, Molecular Cancer Therapeutics.

Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844).

A. Rak, F. Vallée, M. Lowinski, 2016, Journal of medicinal chemistry.